Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 3, 1996, Pages 587-593

  Robinson, S F ^a   Grun, E U ^a   Pauly, J R ^b   Collins, A C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Body temperature; Corticosterone; Heart rate; Locomotor activity; Nicotine; Nicotinic receptors

Indexed keywords

ALPHA BUNGAROTOXIN; CORTICOSTERONE; IODINE 125; NICOTINE; NICOTINIC RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG TOLERANCE; FEMALE; ISOTOPE LABELING; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; TRITIUM;

EID: 0029927136     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02281-3     Document Type: Article

References (41)

1. Barr, J. E.; Holms, D. B.; Ryan, L. M.; Sharpless, S. K. Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol. Biochem. Behav. 11:115-118; 1979.
2. Benwell, M. E. M.; Balfour, D. J. K. Effects of chronic nicotine administration on the response and adaptation to stress. Psychopharmacology (Berlin) 76:160-162; 1982.
3. Clarke, P. B. S.; Kumar, R. The effects of nicotine on locomotor activity in nontolerant and tolerant rats. Br. J. Pharmacol. 78: 329-337; 1983.
4. 125I]-α-bungarotoxin. J. Neurosci. 5:1307-1315; 1985.
5. Collins, A. C.; Romm, E.; Wehner, J. M. Nicotine tolerance: An analysis of the time course of its development and loss in the rat. Psychopharmacology (Berlin) 96:7-14; 1988.
6. Collins, A. C.; Romm, E.; Wehner, J. M. Dissociation of the apparent relationship between nicotine tolerance and upregulation of nicotinic receptors. Brain Res. Bull. 25:373-379; 1990.
7. Cooper, K. O.; Reik, L. M.; Jayyosi, Z.; Bandiera, S.; Kelley, M.; Ryan, D. E.; Daniel, R.; McCluskey, S. A.; Levin, W.; Thomas, P. E. Regulation of two members of the steroid-inducible cytochrome P-450 subfamily (3A) in rats. Arch. Biochem. Biophys. 2:345-354; 1993.
8. Diem, K.; Lentner, C., eds. Documenta Giegy. Scientific tables. 7th ed. Basle, Switzerland: Ciba-Geigy Ltd.; 1970:178-179.
9. Falkeborn, Y.; Larsson, C.; Nordberg, A. Chronic nicotine exposure in rat: A behavioural and biochemical study of tolerance. Drug Alcohol Depend. 8:51-60; 1981.
10. Flores, C. M.; Rogers, S. W.; Pabreza, L. A.; Wolfe, B. B.; Kellar, K. J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41:31-37; 1992.
11. Hatchell, P. C.; Collins, A. C. Influences of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacol. Biochem. Behav. 6:25-30; 1977.
12. Hosteller, K. A.; Wrighton, S. A.; Kremers, P.; Guzelian, P. S. Immunochemical evidence for multiple steroid-inducible hepatic cytochromes P-450 in the rat. Biochem. J. 245:27-33; 1987.
13. Keenan, A.; Johnson, F. N. Development of behavioural tolerance to nicotine in the rat. Experientia 28:428-429; 1972.
14. Lindstrom, J.; Anand, R.; Peng, X.; Gerzanich, V.; Wang, F.; Li, Y. Neuronal nicotinic receptor subtypes. Ann. NY Acad. Sci. 757:100-116; 1995.
15. Lowry, O. H.; Rosebrough, N. H.; Farr, A. C.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
16. Marks, M. J.; Collins, A. C. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol. Pharmacol. 22:554-564; 1982.
17. Marks, M. J.; Burch, J. B.; Collins, A. C. Effects of chronic nicotine infusion on tolerance development and cholinergic receptors. J. Pharmacol. Exp. Ther. 226:806-816; 1983.
18. Marks, M. J.; Campbell, S. M.; Romm, E.; Collins, A. C. Genotype influences the development of tolerance to nicotine in the mouse. J. Pharmacol. Exp. Ther. 259:392-402; 1991.
19. Marks, M. J.; Grady, S. R.; Collins, A. C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266:1268-1276; 1993.
20. Marks, M. J.; Pauly, J. R.; Gross, S. D.; Deneris, E. S.; Hermans-Borgmeyer, I.; Heinemann, S. F.; Collins, A. C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12:2765-2784; 1992.
21. Marks, M. J.; Romm, E.; Bealer, S.; Collins, A. C. A test battery for measuring nicotine effects in mice. Pharmacol. Biochem. Behav. 23:325-330; 1985.
22. Marks, M. J.; Romm, E.; Gaffney, D. E.; Collins, A. C. Nicotine-induced tolerance and receptor changes in four mouse strains. J. Pharmacol. Exp. Ther. 237:809-819; 1986.
23. Marks, M. J.; Stitzel, J. A.; Collins, A. C. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol. Exp. Ther. 235:619-628; 1985.
24. Marks, M. J.; Stitzel, J. A.; Collins, A. C. A dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. J. Pharmacol. Exp. Ther. 239:358-364; 1986.
25. Marks, M. J.; Stitzel, J. A.; Collins, A. C. Influence of kinetics of nicotine administration on tolerance development and receptor levels. Pharmacol. Biochem. Behav. 27:505-512; 1987.
26. Marks, M. J.; Stitzel, J. A.; Romm, E.; Wehner, J. M.; Collins, A. C. Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin. Mol. Pharmacol. 30:427-436; 1986.
27. Pauly, J. R.; Collins, A. C. An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrinology 57:262-271; 1993.
28. 3H] mice. Psychopharmacology (Berlin) 101:310-316; 1990.
29. Pauly, J. R.; Grun, E. A.; Collins, A. C. Glucocorticoid regulation of sensitivity to nicotine. In: Lippiello, P. M.; Collins, A. C.; Gray, J.; Robinson, J., eds. Biology of nicotine. New York: Raven Press; 1992:121-139.
30. Pauly, J. R.; Grun, E. A.; Collins, A. C. Tolerance to nicotine following chronic treatment by injections: A potential role for corticosterone. Psychopharmacology (Berlin) 108:33-39; 1992.
31. Pauly, J. R.; Ullman, E. A.; Collins, A. C. Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacol. Biochem. Behav. 35:171-179; 1990.
32. Petersen, D. R.; Norris, K. J.; Thompson, J. A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab. Dispos. 12:725-731; 1984.
33. Pichard, L.; Fabre, I.; Daujat, M.; Domergue, J.; Joyeux, H.; Maurel, P. Effect of corticosteroids on the expression of cytochromes P-450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol. Pharmacol. 41:1047-1055; 1992.
34. Romano, C.; Goldstein, A. Stereospecific nicotine receptors on rat brain membranes. Science 210:647-650, 1980.
35. Schlechter, M. D.; Rosecrans, J. A. Behavioral tolerance to an effect of nicotine in the rat. Arch. Int. Pharmacodyn. 195:52-56; 1972.
36. Schoepfer, R.; Conroy, W. G.; Whiting, P.; Gore, M.; Lindstrom, J. Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5:35-48, 1990.
37. 3H]-acetylcholine in rat brain. Mol. Pharmacol. 22:56-62, 1982.
38. Stolerman, I. P.; Bunker, P.; Jarvik, M. E. Nicotine tolerance in rats: Role of dose and dose interval. Psychopharmacologia 34: 317-324; 1974.
39. Stolerman, I. P.; Fink, R.; Jarvik, M. E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30:329-342; 1973.
40. Whiting, P.; Schoepfer, R.; Lindstrom, J.; Priestley, T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol. 40:463-472; 1991.
41. Wonnacott, S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11:216-219; 1990.